A panel of experts advising the Food and Drug Administration weighs the safety and effectiveness of the COVID-19 vaccine from Moderna in a daylong public meeting. A committee vote will guide the FDA's decision about authorizing the vaccine for emergency use during the pandemic. The public meeting began at approximately 9 a.m. on Thursday, December 17 and will continue throughout the day.
Stay up to date with the latest news on the coronavirus and COVID-19, the disease caused by the coronavirus. We'll post regular updates from NPR and regional news from the WRVO newsroom. You can also find updates on our live blog.
FDA Panel Weighs Moderna's COVID-19 Vaccine
NPR
